"Pharma Bro" Martin Shkreli is seeking a temporary release from prison to research a treatment for the coronavirus, claiming the pharmaceutical industry's "response to COVID-19 is inadequate." Shkreli became a household name when he jacked up the price of a lifesaving HIV drug 5,000 percent. This quickly earned the former hedge fund manager, investor and pharmaceutical CEO the title of "The most hated man in America." But as American Greed reported in 2018, it was his shady accounting and internet trolling that landed the "Pharma Bro" in hot water. (Original television broadcast: 2/26/2018) Want to binge watch your Greed? Full episodes and the latest news at: https://www.cnbc.com/american-greed/
"Pharma Bro" Martin Shkreli is seeking a temporary release from prison to research a treatment for the coronavirus, claiming the pharmaceutical industry's "response to COVID-19 is inadequate." Shkreli became a household name when he jacked up the price of a lifesaving HIV drug 5,000 percent. This quickly earned the former hedge fund manager, investor and pharmaceutical CEO the title of "The most hated man in America." But as American Greed reported in 2018, it was his shady accounting and internet trolling that landed the "Pharma Bro" in hot water.
(Original television broadcast: 2/26/2018)
Want to binge watch your Greed? Full episodes and the latest news at: https://www.cnbc.com/american-greed/